Literature DB >> 15024621

Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes.

I Tinoco1, J A Girón-González, M T González-González, A Vergara de Campos, L Rodríguez-Félix, A Serrano, A Bascuñana.   

Abstract

With the objective of analyzing the efficacy of directly observed treatment (DOT) of HIV infection in the management of severely immunodepressed patients, this method was examined in individuals cared for in two social welfare facilities for HIV-infected persons and compared to self-administered therapy in outpatients. Forty-seven patients with registered HIV infection, stage C, were assigned to DOT for 9 months, the majority of whom had previously received antiretroviral therapy. A group of 51 HIV-infected outpatients, who attended day clinics attached to the reference hospitals, served as a comparison group. Together with increases in weight (9.2+/-7.5 kg) and Karnofsky scores (16.9+/-12.2) in the DOT group, a significant improvement of surrogate markers, such as CD4+ T-cell counts (increase in DOT group, 113.4+/-151.0 cells/microl; control group, -2.8+/-114.1 cells/microl; P<0.001) and HIV load (decrease in DOT group, -1.7+/-2.3 log10 copies/ml; control group, -0.4+/-1.5 log10 copies/ml; P<0.01) was detected in the DOT group. Morbidity and mortality were similar in both groups. The results indicate that such welfare facilities provide a useful framework not only for social objectives but also for healthcare purposes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024621     DOI: 10.1007/s10096-003-1099-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Modified directly observed therapy for treatment of human immunodeficiency virus.

Authors:  J A Mitty; M McKenzie; M Stenzel; T Flanigan; C C Carpenter
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

2.  Directly observed therapy in HIV therapy: A realistic perspective?

Authors:  M Lanzafame; M Trevenzoli; A M Cattelan; P Rovere; A Parrinello
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

3.  Directly observed therapy to treat HIV infection in prisoners.

Authors:  S Babudieri; A Aceti; G P D'Offizi; S Carbonara; G Starnini
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

4.  Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.

Authors:  Donato Torre; Roberto Tambini
Journal:  HIV Clin Trials       Date:  2002 Jan-Feb

5.  Adherence and antiretroviral therapy in injection drug users.

Authors:  R Sherer
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

6.  Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients.

Authors:  A López-Suárez; E Pérez-Guzmán; J A Girón-González
Journal:  AIDS       Date:  1998-04-16       Impact factor: 4.177

7.  Should directly observed therapy be considered for treatment of HIV?

Authors:  W C Woodward
Journal:  JAMA       Date:  1996-12-25       Impact factor: 56.272

Review 8.  Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.

Authors:  V E Stone
Journal:  Clin Infect Dis       Date:  2001-08-13       Impact factor: 9.079

9.  Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.

Authors:  Hernando Knobel; Jordi Alonso; José L Casado; Julio Collazos; Juan González; Isabel Ruiz; José M Kindelan; Alexia Carmona; Javier Juega; Antonio Ocampo
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

10.  AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Authors:  B Ledergerber; M Egger; V Erard; R Weber; B Hirschel; H Furrer; M Battegay; P Vernazza; E Bernasconi; M Opravil; D Kaufmann; P Sudre; P Francioli; A Telenti
Journal:  JAMA       Date:  1999-12-15       Impact factor: 56.272

View more
  10 in total

1.  Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Authors:  Duncan Smith-Rohrberg Maru; R Douglas Bruce; Mary Walton; Jo Anne Mezger; Sandra A Springer; David Shield; Frederick L Altice
Journal:  AIDS Behav       Date:  2007-12-18

2.  Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.

Authors:  Duncan Smith-Rohrberg Maru; Michael J Kozal; R Douglas Bruce; Sandra A Springer; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-15       Impact factor: 3.731

3.  Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.

Authors:  Ali Shabahang Saber-Tehrani; Sandra A Springer; Jingjun Qiu; Maua Herme; Jeffrey Wickersham; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2011-11-12       Impact factor: 2.226

Review 4.  A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs.

Authors:  Meredith Camp Binford; Shoshana Y Kahana; Frederick L Altice
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

Review 5.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

6.  Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Authors:  Karina M Berg; Alain Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

7.  Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.

Authors:  Chinazo O Cunningham; Nancy L Sohler; Nina A Cooperman; Karina M Berg; Alain H Litwin; Julia H Arnsten
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

8.  Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Authors:  Karina M Berg; Alain H Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Clin Infect Dis       Date:  2011-09-02       Impact factor: 9.079

9.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

10.  Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Mary Walton; Sandra A Springer; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.